AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33243764 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐Item General Health Questionnaire (CMDs)
Number of subjects: 1092
Study 33243764 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐Item Dimensions of Anger Reactions‐Revised
Number of subjects: 1092
Study 33243764 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol Use Disorders Identification Test
Number of subjects: 1092
Study 33243764 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support and stressors related to COVID-19
Number of subjects: 1092
Study 34584871 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional pediatric nursing teaching model combined with the humanistic care teaching model
Number of subjects: 68
Study 34584871 — intervention group
Group type: COMPARATOR
Intervention: Traditional pediatric nursing teaching model
Number of subjects: 68
Study 34584871 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after training
Number of subjects: 68
Study 32145131 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral nerve field stimulation (PNFS)
Number of subjects: 0
Study 35980240 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick, self-etch mode (CUQ-SE)
Number of subjects: 34
Study 35980240 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (self-etch adhesive) (CSEB)
Number of subjects: 34
Study 35980240 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric N-Bond Universal, etch-and-rinse mode (TBU-ER)
Number of subjects: 34
Study 35980240 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick, selective etch mode (CUQ-SLE)
Number of subjects: 34
Study 35980240 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick, etch-and-rinse mode (CUQ-ER)
Number of subjects: 34
Study 32755273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (600 mg oral dose)
Number of subjects: 23
Study 32755273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 36044330 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with multijoint to single-joint and upper- to lower-body
Number of subjects: 61
Study 36044330 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with single-joint to multijoint and upper- to lower-body
Number of subjects: 61
Study 36044330 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with multijoint to single-joint and lower- to upper-body
Number of subjects: 61
Study 36044330 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with single-joint to multijoint and lower- to upper-body
Number of subjects: 61
Study 33439308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity (HI) eccentric cycling (5 x 1-min at 20% peak power output)
Number of subjects: 20
Study 33439308 — intervention group
Group type: COMPARATOR
Intervention: Lower-intensity (LI) eccentric cycling (5 x 4-min at 5% peak power output)
Number of subjects: 20
Study 33439308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity (HI) eccentric cycling
Number of subjects: 20
Study 33439308 — intervention group
Group type: COMPARATOR
Intervention: Lower-intensity (LI) eccentric cycling
Number of subjects: 20
Study 32390102 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta-Beta Neurofeedback Training (NFT) with placebo instruction
Number of subjects: 22
Study 32390102 — intervention group
Group type: COMPARATOR
Intervention: Theta-Beta Neurofeedback Training (NFT) with standard instruction
Number of subjects: 22
Study 34936861 — intervention group
Group type: EXPERIMENTAL
Intervention: VEST-supported saphenous vein grafts
Number of subjects: 0
Study 34936861 — intervention group
Group type: COMPARATOR
Intervention: Unsupported saphenous vein grafts
Number of subjects: 0
Study 32093757 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory intervention (SI) to improve quality of life for PwD with concurrent hearing and/or vision impairment.
Number of subjects: 0
Study 32093757 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 35061005 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine group (10 ml liposomal bupivacaine + 10 ml 0.5% bupivacaine)
Number of subjects: 22
Study 35061005 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine group (20 ml 0.5% bupivacaine)
Number of subjects: 22
Study 35061005 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine group
Number of subjects: 22
Study 35061005 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine group
Number of subjects: 22
Study 34103030 — intervention group
Group type: EXPERIMENTAL
Intervention: peer modelling plus discussion (MD)
Number of subjects: 141
Study 34103030 — intervention group
Group type: COMPARATOR
Intervention: non-peer modelled example (NM)
Number of subjects: 141
Study 34103030 — intervention group
Group type: EXPERIMENTAL
Intervention: peer modelling without discussion (M)
Number of subjects: 141
Study 32019584 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary horse-assisted therapy (cHAT)
Number of subjects: 50
Study 32019584 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU-only)
Number of subjects: 50
Study 35944269 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychoeducation intervention added to treatment-as-usual (n = 24)
Number of subjects: 51
Study 35944269 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control group, n = 27)
Number of subjects: 51
Study 35944269 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 51
Study 33386748 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine clinical care with a greater emphasis on surgery by skilled endoscopic gynaecologists
Number of subjects: 500
Study 33386748 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care with more medical expertise in managing pain and menstrual problems
Number of subjects: 500
Study 32771011 — intervention group
Group type: EXPERIMENTAL
Intervention: PA4E1 program group (n = 24)
Number of subjects: 49
Study 32771011 — intervention group
Group type: COMPARATOR
Intervention: Usual practice control (n = 25)
Number of subjects: 49
Study 36107676 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-supported mobile mental health intervention (4 phone sessions over 8 weeks, introduction to 5 mobile apps for mental health issues)
Number of subjects: 39
Study 33418490 — intervention group
Group type: EXPERIMENTAL
Intervention: RESMENA diet (high meal frequency and high adherence to the Mediterranean diet)
Number of subjects: 24
Study 33418490 — intervention group
Group type: COMPARATOR
Intervention: American Heart Association diet (control)
Number of subjects: 24
Study 37306272 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided PECS II block
Number of subjects: 50
Study 37306272 — intervention group
Group type: COMPARATOR
Intervention: US-guided SAP block
Number of subjects: 50
Study 33594415 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep propensity network using a sparse autoencoder (DPN-SA)
Number of subjects: 0
Study 33594415 — intervention group
Group type: COMPARATOR
Intervention: Logistic regression
Number of subjects: 0
Study 33594415 — intervention group
Group type: COMPARATOR
Intervention: LASSO
Number of subjects: 0
Study 33594415 — intervention group
Group type: COMPARATOR
Intervention: Deep counterfactual networks with propensity dropout (DCN-PD)
Number of subjects: 0
Study 32727493 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the Psychosocial Assessment Tool (PAT) with training and expanded resources
Number of subjects: 19
Study 32727493 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the Psychosocial Assessment Tool (PAT)
Number of subjects: 19
Study 36364949 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education about eating balanced meals from first trimester until delivery
Number of subjects: 893
Study 36364949 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 893
Study 36364949 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 893
Study 32684463 — intervention group
Group type: COMPARATOR
Intervention: Stepwise reduction in milk allowance (STEP: 8 L/d of MR from d 14 to 28; 5 L/d from d 29 to 42; 4 L/d from d 43 to 49; 2 L/d from d 50 to 56 of age)
Number of subjects: 64
Study 32684463 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional flat-rate milk allowance (CON: 6.5 L/d of MR from d 14 to 42; 4 L/d from d 43 to 49; 2 L/d from d 50 to 56 of age)
Number of subjects: 64
Study 32684463 — intervention group
Group type: EXPERIMENTAL
Intervention: Unrestricted portion size (UNRES)
Number of subjects: 64
Study 32684463 — intervention group
Group type: COMPARATOR
Intervention: Restricted portion size (RES: maximum milk portion size of 2.3 L/portion)
Number of subjects: 64
Study 32684463 — intervention group
Group type: EXPERIMENTAL
Intervention: UNRES treatment among CON calves
Number of subjects: 64
Study 34355514 — intervention group
Group type: EXPERIMENTAL
Intervention: Chispuditos® (atole fortified with micronutrients)
Number of subjects: 971
Study 34355514 — intervention group
Group type: COMPARATOR
Intervention: Lactose-free milk
Number of subjects: 971
Study 33728824 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 0
Study 33728824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33728824 — intervention group
Group type: EXPERIMENTAL
Intervention: Smell training
Number of subjects: 0
Study 32649578 — intervention group
Group type: EXPERIMENTAL
Intervention: Kissing slide method
Number of subjects: 64
Study 32649578 — intervention group
Group type: COMPARATOR
Intervention: Conventional swab method
Number of subjects: 64
Study 35014040 — intervention group
Group type: EXPERIMENTAL
Intervention: GB004 120 mg once daily for 28 days
Number of subjects: 34
Study 35014040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 32959058 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib-containing chemotherapy (ADEB)
Number of subjects: 483
Study 32959058 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (ADE)
Number of subjects: 483
Study 32470389 — intervention group
Group type: EXPERIMENTAL
Intervention: More-intensive renal replacement therapy (hemodialysis or sustained low-efficiency dialysis six times per week or continuous venovenous hemodiafiltration at 35 mL/kg per hour)
Number of subjects: 907
Study 32470389 — intervention group
Group type: COMPARATOR
Intervention: Less-intensive renal replacement therapy (hemodialysis or sustained low-efficiency dialysis three times per week or continuous venovenous hemodiafiltration at 20 mL/kg per hour)
Number of subjects: 907
Study 36216984 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy-Emotion Development (PCIT-ED)
Number of subjects: 229
Study 33160871 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive pharmacist intervention group
Number of subjects: 182
Study 33160871 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 182
Study 32964818 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (three 50‐minute yoga classes/week for 10 weeks)
Number of subjects: 52
Study 32964818 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 52
Study 32964818 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 34537804 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric-based (ECC) resistance training
Number of subjects: 60
Study 34537804 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional concentric-eccentric (TRAD) resistance training
Number of subjects: 60
Study 34537804 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 33710918 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dissection (BD)
Number of subjects: 40
Study 33710918 — intervention group
Group type: COMPARATOR
Intervention: Camera dissection (CD)
Number of subjects: 40
Study 32173464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 500 mg
Number of subjects: 80
Study 32173464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg
Number of subjects: 80
Study 32173464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg (PD-L1-positive)
Number of subjects: 80
Study 32173464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg (PD-L1-high)
Number of subjects: 80
Study 32173464 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-related adverse events
Number of subjects: 80
Study 32173464 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-related adverse events leading to discontinuation
Number of subjects: 80
Study 34453573 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior part middle turbinoplasty
Number of subjects: 120
Study 34453573 — intervention group
Group type: COMPARATOR
Intervention: Preservation of the middle turbinate
Number of subjects: 120
Study 34453573 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Anterior part middle turbinoplasty and Preservation of the middle turbinate)
Number of subjects: 120
Study 34855648 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium patches (150 mg/day, increased to 225 mg/day)
Number of subjects: 238
Study 34855648 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium patches
Number of subjects: 238
Study 34855648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 34969566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (2.5 mg/kg)
Number of subjects: 67
Study 34969566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 34454044 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine for 7 days plus azithromycin for 5 days
Number of subjects: 84
Study 34454044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 36396114 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent‐scanning continuous glucose monitoring (isCGM) device combined with structured education
Number of subjects: 104
Study 36396114 — intervention group
Group type: COMPARATOR
Intervention: Self‐monitoring of blood glucose (SMBG)
Number of subjects: 104
Study 36396114 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (isCGM + structured education)
Number of subjects: 104
Study 36396114 — intervention group
Group type: COMPARATOR
Intervention: Control (SMBG)
Number of subjects: 104
Study 33683659 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted cancer drugs as monotherapies
Number of subjects: 223
Study 33683659 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies with targeted cancer drugs
Number of subjects: 223
Study 32485781 — intervention group
Group type: EXPERIMENTAL
Intervention: 880 μg fluticasone furoate administered intranasally
Number of subjects: 18
Study 35527579 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqua‐PLYO training program
Number of subjects: 56
Study 35527579 — intervention group
Group type: COMPARATOR
Intervention: Standard physical therapy (Control group)
Number of subjects: 56
Study 33141477 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide econazole cream (TAEC)
Number of subjects: 786
Study 33141477 — intervention group
Group type: COMPARATOR
Intervention: Nystatin suspension
Number of subjects: 786
Study 33738521 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogatherapy
Number of subjects: 89
Study 33738521 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 89
Study 34384042 — intervention group
Group type: COMPARATOR
Intervention: Standard 'ask-advise-refer' care (Arm 1)
Number of subjects: 3200
Study 34384042 — intervention group
Group type: EXPERIMENTAL
Intervention: Free or subsidized pharmacologic cessation aids (Arm 2)
Number of subjects: 3200
Study 34384042 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives up to $600 for cessation (Arm 3)
Number of subjects: 3200
Study 34384042 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile device-delivered episodic future thinking tool (Arm 4)
Number of subjects: 3200
Study 32446787 — intervention group
Group type: EXPERIMENTAL
Intervention: Target fortification of breast milk (modular protein, lipids, carbohydrates)
Number of subjects: 103
Study 32446787 — intervention group
Group type: COMPARATOR
Intervention: Standard fortification of breast milk
Number of subjects: 103
Study 32446787 — intervention group
Group type: EXPERIMENTAL
Intervention: Target fortification of breast milk
Number of subjects: 103
Study 33089767 — intervention group
Group type: EXPERIMENTAL
Intervention: Question Listing
Number of subjects: 324
Study 33089767 — intervention group
Group type: EXPERIMENTAL
Intervention: Question Prompt Sheet
Number of subjects: 324
Study 33089767 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaccompanied patients
Number of subjects: 324
Study 33089767 — intervention group
Group type: COMPARATOR
Intervention: Accompanied patients
Number of subjects: 324
Study 32773223 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride (TG) levels ≥150 mg/dL
Number of subjects: 2307
Study 35894933 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin 20 mg once daily
Number of subjects: 40
Study 35894933 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride 0.5 mg once daily
Number of subjects: 40
Study 34787280 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session laser at 810 nm (20 teeth)
Number of subjects: 40
Study 34787280 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session laser at 940 nm (20 teeth)
Number of subjects: 40
Study 34787280 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated laser sessions at 810 nm (20 teeth)
Number of subjects: 40
Study 34787280 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated laser sessions at 940 nm (20 teeth)
Number of subjects: 40
Study 33080291 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine
Number of subjects: 0
Study 33080291 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine
Number of subjects: 0
Study 33080291 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nicotine-free taste-matched chewing gum)
Number of subjects: 0
Study 35377878 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated mass drug administration (MDA) for STH and mass dog rabies vaccination (MDRV)
Number of subjects: 0
Study 35377878 — intervention group
Group type: COMPARATOR
Intervention: MDA only
Number of subjects: 0
Study 35377878 — intervention group
Group type: COMPARATOR
Intervention: MDRV only
Number of subjects: 0
Study 32332664 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous thoracic paravertebral block (PVB)
Number of subjects: 180
Study 32332664 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 180
Study 33159734 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-isometric relaxation
Number of subjects: 60
Study 33159734 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial trigger point release
Number of subjects: 60
Study 33159734 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine physical therapy
Number of subjects: 60
Study 36328878 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (twice a week for twelve weeks, 60 min sessions including warm-up, progressive resistance training, and cool-down)
Number of subjects: 40
Study 36328878 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (twice a week for twelve weeks)
Number of subjects: 40
Study 36328878 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 40
Study 33654266 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome-wide association study
Number of subjects: 1067
Study 33654266 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 1067
Study 33654266 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk scoring
Number of subjects: 1067
Study 32816521 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking boot treatment
Number of subjects: 140
Study 32816521 — intervention group
Group type: COMPARATOR
Intervention: Cast treatment
Number of subjects: 140
Study 34516646 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Improvers
Number of subjects: 327
Study 34516646 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Improvers
Number of subjects: 327
Study 32514607 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 32
Study 32514607 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 32
Study 32514607 — intervention group
Group type: COMPARATOR
Intervention: Control (follow-up)
Number of subjects: 32
Study 32251233 — intervention group
Group type: EXPERIMENTAL
Intervention: Azurion 7 F12 angiography system
Number of subjects: 238
Study 32251233 — intervention group
Group type: COMPARATOR
Intervention: Allura Xper system
Number of subjects: 238
Study 32706906 — intervention group
Group type: EXPERIMENTAL
Intervention: CLIF Consortium Acute Decompensation score (CLIF-C ADs)
Number of subjects: 608
Study 32706906 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram incorporating components of CLIF-C ADs and albumin, platelet, active bleeding, ascites
Number of subjects: 608
Study 32706906 — intervention group
Group type: COMPARATOR
Intervention: Active bleeding at endoscopy
Number of subjects: 608
Study 32706906 — intervention group
Group type: COMPARATOR
Intervention: Other prognostic models
Number of subjects: 608
Study 34518257 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracurricular research programme (ERP) participation
Number of subjects: 315
Study 34518257 — intervention group
Group type: COMPARATOR
Intervention: Control group (students showing ERP-interest only)
Number of subjects: 315
Study 32472567 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 344
Study 32472567 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study 36372613 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanins (320 mg/d for 24 weeks)
Number of subjects: 206
Study 36372613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study 34459211 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 2571